GlucoTrack: Below) To Reflect The Terms Of The Exchange Agreement, Which Supersedes And Replaces In Its Entirety The Exchange Agreement Dated July 22, 2026 (the “original Exchange Agreement”) Previously Filed As Exhibit 10.1 To The Original Report, And (ii) File The Exchange Agreement As Exhibit 10.1 To This Amendment. This Amendment Amends And Restates The Original Report In Its Entirety, And The Original Exchange Agreement Is Hereby Superseded And Replaced In Its Entirety By The Exchange Agreement Attached As Exhibit 10.1 To This Amendment, Creation Of A Direct Financial Obligation Or An Obligation Under An Offbalance Sheet Arrangement Of A Registrant, Unregistered Sales Of Equity Securities, Financial Statements And Exhibits

Show full article

This functionality is available for registred users only

• Full name
  GlucoTrack Inc (formerly Integrity Applications Inc)
• Registration country
  USA
• Industry
  Medical Devices
• М/S&P/F
  *** / *** / ***